Creatine supplementation in healthy humans is linked to overactive platelets, shown by increased clumping and activation markers, and this increases the risk of tumors spreading to other parts of the body.
See the scientific wording
Creatine supplementation in healthy human volunteers is associated with hyperactive peripheral platelets, as measured by increased platelet aggregation and activation markers, and may increase the risk of tumor metastasis.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cross-Sectional StudyHuman2026
The study found that healthy people who took creatine supplements had more active platelets, which might help cancer cells spread if they had cancer.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When a person takes creatine supplements, creatine enters cells that make platelets. This tells the cells to make more of a protein called CKB. CKB then attaches a phosphate group to another protein called STAT5B, which turns on genes that make platelets overly active. These hyperactive platelets stick together more easily and can help cancer cells spread through the blood to form new tumors.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Creatine supplementation in healthy humans is linked to overactive platelets, shown by increased clumping and activation markers, and this increases the risk of tumors spreading to other parts of the body.
Mechanism
1 studyCreatine supplements boost creatine in platelet-making cells, which turns on a series of molecular events. This makes platelets super sticky, and if a person has cancer, these sticky platelets can help cancer cells travel through the blood and form new tumors.
When a person takes creatine supplements, creatine enters cells that make platelets. This tells the cells to make more of a protein called CKB. CKB then attaches a phosphate group to another protein called STAT5B, which turns on genes that make platelets overly active. These hyperactive platelets stick together more easily and can help cancer cells spread through the blood to form new tumors.
Creatine supplementation increases creatine levels in megakaryocytes, the precursor cells that produce platelets.
Elevated creatine levels upregulate creatine kinase B (CKB) expression in megakaryocytes.
CKB mediates non-canonical phosphorylation of STAT5B, a transcription factor, at specific tyrosine residues.
Phosphorylated STAT5B translocates to the nucleus and activates transcription of platelet functional genes, including those involved in aggregation and adhesion.
The gene expression changes lead to the production of hyperactive platelets with increased aggregation and activation markers.
Hyperactive platelets promote tumor metastasis by enhancing tumor cell survival, adhesion to endothelium, and extravasation.
Evidence from Studies
Supporting (1)
Community contributions welcome
Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling.
The study found that healthy people who took creatine supplements had more active platelets, which might help cancer cells spread if they had cancer.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Creatine Supplementation and Platelet Aggregation in Healthy Humans
Systematic review of RCTs and cohort studies that measured platelet aggregation markers or tumor metastasis incidence in creatine users vs non-users.
Double-Blind RCT of Creatine vs Placebo on Platelet Aggregation and Activation Markers in Healthy Adults
Randomized, double-blind, placebo-controlled trial with 100 healthy adults, assessing platelet aggregation (e.g., light transmission aggregometry) and activation markers (e.g., P-selectin) at baseline and after 8 weeks of creatine (20g/day loading then 5g/day maintenance) vs placebo.
Prospective Cohort of Creatine Use and Tumor Metastasis Incidence in Cancer Patients
Prospective cohort of 10,000 cancer patients (e.g., breast, colon) with regular creatine use data, followed for 5 years for metastasis occurrence, adjusting for confounders.
Case-Control Study of Platelet Hyperactivity in Cancer Patients with and without Creatine Supplementation
Retrospective case-control of 500 cancer patients: cases with high platelet aggregation values, controls with normal values; assess creatine use history via questionnaires.
In Vitro Study of Creatine on Human Platelet Aggregation and Tumor Cell Adhesion
Incubate human platelets with physiological concentrations of creatine (0.1-1 mM) and measure aggregation (e.g., turbidometry) and adhesion to cancer cells (e.g., melanoma or breast cancer lines) under flow conditions.